España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sangamo Therapeutics
SGMO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.17
-0.06
-4.88%
At close: -
$1.19
0.02
1.71%
After Hours: 7:07 PM EDT
Get Report
Comment
Sangamo Therapeutics (SGMO) Forecast
News
Earnings
Sangamo Therapeutics (SGMO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sangamo Therapeutics (NASDAQ:SGMO) Stock
Sangamo Therapeutics Stock (NASDAQ: SGMO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 27, 2025
Expert Outlook: Sangamo Therapeutics Through The Eyes Of 11 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Thursday, January 23, 2025
Truist Securities Maintains Buy on Sangamo Th...
Benzinga Newsdesk
Thursday, January 02, 2025
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Tuesday, December 31, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Jefferies Maintains Buy on Sangamo Therapeuti...
Benzinga Newsdesk
Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide
Avi Kapoor
9 Analysts Have This To Say About Sangamo Therapeutics
Benzinga Insights
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet
Avi Kapoor
US Stocks Open Higher; House Prices Increase In October
Avi Kapoor
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Vandana Singh
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
Avi Kapoor
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Sangamo Therapeutics shares are trading lower...
Benzinga Newsdesk
Market-Moving News for December 31st
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Sangamo...
Benzinga Newsdesk
Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
US Stocks Poised To Open Higher On Last Trading Day Of 2024: Analyst Sees S&P 500 At 7,000 In First Half Of 2025
Rishabh Mishra
CompoSecure, Cemtrex And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
Monday, December 30, 2024
Sangamo shares are trading lower after the co...
Benzinga Newsdesk
Sangamo Says Collaboration, License Agreement...
Benzinga Newsdesk
Sangamo Therapeutics Reveals Pfizer's Decisio...
Benzinga Newsdesk
Friday, December 20, 2024
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Thursday, December 19, 2024
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Sangamo Therapeutics shares are trading highe...
Benzinga Newsdesk
US Stocks Likely To Open Higher After Plunging On Powell's Hawkish Comments: Analyst Calls It A 'Healthy' Reaction From An 'Overly Optimistic' Market
Rishabh Mishra
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Sangamo Licenses STAC-BBB Technology To Astel...
Benzinga Newsdesk
Monday, December 16, 2024
Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Tuesday, December 10, 2024
The Analyst Landscape: 6 Takes On Sangamo Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Tuesday, November 26, 2024
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Tuesday, November 19, 2024
Sangamo Therapeutics shares are trading highe...
Benzinga Newsdesk
Sangamo Therapeutics Gains FDA Clearance For ...
Benzinga Newsdesk
Thursday, November 14, 2024
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Wednesday, November 13, 2024
Sangamo Therapeutics shares are trading lower...
Benzinga Newsdesk
Tuesday, November 12, 2024
Sangamo Therapeutics Q3 EPS $0.04 Beats $(0.0...
Benzinga Newsdesk
Zeta Global, Spirit Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Sangamo Therapeutics's Earnings Outlook
Benzinga Insights
Tuesday, November 05, 2024
Sangamo Therapeutics shares are trading highe...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Sangamo ...
Benzinga Newsdesk
Friday, October 25, 2024
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, October 23, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Sangamo Therapeutics shares are trading highe...
Benzinga Newsdesk
4 Analysts Have This To Say About Sangamo Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Tuesday, October 22, 2024
Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results
Avi Kapoor
What's Going On With Sangamo Therapeutics Shares Tuesday?
Dylan Berman
Crude Oil Rises Sharply; 3M Posts Upbeat Earnings
Avi Kapoor
Show More